Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease.
Schwartz GG, Leiter LA, Ballantyne CM, Barter PJ, Black DM, Kallend D, Laghrissi-Thode F, Leitersdorf E, McMurray JJV, Nicholls SJ, Olsson AG, Preiss D, Shah PK, Tardif JC, Kittelson J.
Schwartz GG, et al. Among authors: leiter la.
Diabetes Care. 2020 May;43(5):1077-1084. doi: 10.2337/dc19-2204. Epub 2020 Mar 6.
Diabetes Care. 2020.
PMID: 32144166
Free PMC article.
Clinical Trial.